Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 25.92 CHF -4.71% Market Closed
Market Cap: 973.9m CHF
Have any thoughts about
Kuros Biosciences AG?
Write Note

Intrinsic Value

The intrinsic value of one KURN stock under the Base Case scenario is 5.47 CHF. Compared to the current market price of 25.92 CHF, Kuros Biosciences AG is Overvalued by 79%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KURN Intrinsic Value
5.47 CHF
Overvaluation 79%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Kuros Biosciences AG

Valuation History Unavailable

Historical valuation for KURN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
Compare KURN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KURN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Kuros Biosciences AG

Provide an overview of the primary business activities
of Kuros Biosciences AG.

What unique competitive advantages
does Kuros Biosciences AG hold over its rivals?

What risks and challenges
does Kuros Biosciences AG face in the near future?

Has there been any significant insider trading activity
in Kuros Biosciences AG recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kuros Biosciences AG.

Provide P/S
for Kuros Biosciences AG.

Provide P/E
for Kuros Biosciences AG.

Provide P/OCF
for Kuros Biosciences AG.

Provide P/FCFE
for Kuros Biosciences AG.

Provide P/B
for Kuros Biosciences AG.

Provide EV/S
for Kuros Biosciences AG.

Provide EV/GP
for Kuros Biosciences AG.

Provide EV/EBITDA
for Kuros Biosciences AG.

Provide EV/EBIT
for Kuros Biosciences AG.

Provide EV/OCF
for Kuros Biosciences AG.

Provide EV/FCFF
for Kuros Biosciences AG.

Provide EV/IC
for Kuros Biosciences AG.

Show me price targets
for Kuros Biosciences AG made by professional analysts.

What are the Revenue projections
for Kuros Biosciences AG?

How accurate were the past Revenue estimates
for Kuros Biosciences AG?

What are the Net Income projections
for Kuros Biosciences AG?

How accurate were the past Net Income estimates
for Kuros Biosciences AG?

What are the EPS projections
for Kuros Biosciences AG?

How accurate were the past EPS estimates
for Kuros Biosciences AG?

What are the EBIT projections
for Kuros Biosciences AG?

How accurate were the past EBIT estimates
for Kuros Biosciences AG?

Compare the revenue forecasts
for Kuros Biosciences AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kuros Biosciences AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kuros Biosciences AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kuros Biosciences AG compared to its peers.

Compare the P/E ratios
of Kuros Biosciences AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Kuros Biosciences AG with its peers.

Analyze the financial leverage
of Kuros Biosciences AG compared to its main competitors.

Show all profitability ratios
for Kuros Biosciences AG.

Provide ROE
for Kuros Biosciences AG.

Provide ROA
for Kuros Biosciences AG.

Provide ROIC
for Kuros Biosciences AG.

Provide ROCE
for Kuros Biosciences AG.

Provide Gross Margin
for Kuros Biosciences AG.

Provide Operating Margin
for Kuros Biosciences AG.

Provide Net Margin
for Kuros Biosciences AG.

Provide FCF Margin
for Kuros Biosciences AG.

Show all solvency ratios
for Kuros Biosciences AG.

Provide D/E Ratio
for Kuros Biosciences AG.

Provide D/A Ratio
for Kuros Biosciences AG.

Provide Interest Coverage Ratio
for Kuros Biosciences AG.

Provide Altman Z-Score Ratio
for Kuros Biosciences AG.

Provide Quick Ratio
for Kuros Biosciences AG.

Provide Current Ratio
for Kuros Biosciences AG.

Provide Cash Ratio
for Kuros Biosciences AG.

What is the historical Revenue growth
over the last 5 years for Kuros Biosciences AG?

What is the historical Net Income growth
over the last 5 years for Kuros Biosciences AG?

What is the current Free Cash Flow
of Kuros Biosciences AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kuros Biosciences AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kuros Biosciences AG

Current Assets 55.1m
Cash & Short-Term Investments 18m
Receivables 19.9m
Other Current Assets 17.2m
Non-Current Assets 48.9m
PP&E 3.7m
Intangibles 42.3m
Other Non-Current Assets 2.9m
Current Liabilities 25.7m
Accounts Payable 8.5m
Accrued Liabilities 16.6m
Other Current Liabilities 650.8k
Non-Current Liabilities 6m
Long-Term Debt 5.4m
Other Non-Current Liabilities 579.4k
Efficiency

Free Cash Flow Analysis
Kuros Biosciences AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kuros Biosciences AG

Revenue
92.9m CHF
Cost of Revenue
-10.4m CHF
Gross Profit
82.6m CHF
Operating Expenses
-82.5m CHF
Operating Income
131.6k CHF
Other Expenses
-5.4m CHF
Net Income
-5.3m CHF
Fundamental Scores

KURN Profitability Score
Profitability Due Diligence

Kuros Biosciences AG's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
37/100
Profitability
Score

Kuros Biosciences AG's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

KURN Solvency Score
Solvency Due Diligence

Kuros Biosciences AG's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Negative Net Debt
Long-Term Solvency
72/100
Solvency
Score

Kuros Biosciences AG's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KURN Price Targets Summary
Kuros Biosciences AG

There are no price targets for KURN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Kuros Biosciences AG
does not pay dividends
Shareholder Yield

Current shareholder yield for KURN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KURN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KURN stock?

The intrinsic value of one KURN stock under the Base Case scenario is 5.47 CHF.

Is KURN stock undervalued or overvalued?

Compared to the current market price of 25.92 CHF, Kuros Biosciences AG is Overvalued by 79%.

Back to Top